)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Genus
Genus (GNS) investor relations material
Genus Trading update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Trading update summary14 Jul, 2026
Financial performance
Second half trading exceeded expectations, driven by strong growth in Asia and Latin America, offsetting North American challenges.
Adjusted profit before tax for FY26 is expected to be about £98m, ahead of the consensus range midpoint of £95.5m.
Double-digit profit growth in ABS was achieved, supported by the Value Acceleration Programme despite softer demand and lower dairy prices.
Free cash flow generation saw significant growth, with strong cash conversion in the second half.
Net leverage at year-end is projected to fall to approximately 0.4x, aided by a £111m net cash inflow from a Chinese joint venture.
Strategic and operational highlights
Successful formation of a Chinese porcine joint venture resulted in a substantial cash inflow.
The business enters FY27 with a strengthened balance sheet and a focus on strategic priorities.
Continued innovation in gene editing, with the PRRS Resistant Pig positioned for future commercialisation pending regulatory approval.
Outlook
The group is well positioned for FY27, with preliminary FY26 results to be announced on 10 September 2026.
North American PIC disease challenge impact
Value Acceleration Programme impact on ABS margins
Future use of BCA joint venture cash proceeds
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Genus
- Record H1 profit, strong PIC and ABS growth, and major China JV drive positive FY26 outlook.GNS
H1 20269 Jul 2026 - Profit growth expected in FY25 after strategic gains and cost savings, despite market challenges.GNSH2 202422 Jan 2026
- Profit fell as China and ABS faced headwinds, but margin and PRP progress continued.GNSH2 2024 (Q&A)22 Jan 2026
- Market leadership, innovation in gene editing, and China expansion drive strong growth prospects.GNS44th Annual J.P. Morgan Healthcare Conference Presentation16 Jan 2026
- Profit outlook raised above expectations after strong H1 and China joint venture progress.GNSTrading update16 Jan 2026
- Profit outlook raised to top end of expectations as both ABS and PIC segments outperform.GNSTrading Update7 Jan 2026
- Strong H1 profit growth, margin gains, and strategic progress drive a positive outlook.GNSH1 202529 Dec 2025
- Record profit growth, China JV acceleration, and FDA PRP approval drive strong FY25 results.GNSH2 20254 Sep 2025
- Strong trading, milestone receipts, and robust cash flow drive FY25 profit in line with guidance.GNSTrading Update17 Jul 2025
Next Genus earnings date
H2 202610 Sep, 2026
Genus
Next Genus earnings date
H2 202610 Sep, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage